Document Detail

Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer. A retrospective analysis of the Southern Italy Cooperative Oncology Group trials.
MedLine Citation:
PMID:  17702595     Owner:  NLM     Status:  MEDLINE    
We retrospectively assessed tolerability and efficacy of paclitaxel plus gemcitabine combination in 259 patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) enrolled in three randomized SICOG trials according to their age (<or=70 or >70 years) at study entry. Apart from age, demographic and clinical characteristics were similar in the two groups. Response rate of paclitaxel plus gemcitabine was similar in younger and in elderly (36% versus 30%). Chemotherapy was well tolerated, but severe neutropenia (12% versus 7%), anaemia (6.6% versus 1.8%), and vomiting (5% versus 0) were more frequent in elderly patients. Both median progression-free survival (PFS, 5.5 months versus 4.2 months), and overall survival (OS, 11.1 months versus 9.1 months) resulted slightly prolonged for younger patients. However, only stage and performance status resulted independently affecting PFS and OS. In conclusion, paclitaxel plus gemcitabine were similarly tolerated and active in younger and elderly patients. This regimen should be considered an option for the management of fit elderly patients.
Pasquale Comella; Antonio Gambardella; Giuseppe Frasci; Antonio Avallone; Raffaele Costanzo;
Related Documents :
2996745 - Primary signet-ring carcinoma of the large bowel. report of nine cases.
20131995 - Benefit of adjuvant chemotherapy in elderly er-negative breast cancer patients: benefit...
15607935 - Treatment of head and neck cancer in elderly patients: state of the art and guidelines.
2371175 - Relationship of age to histologic grade in prostate cancer.
22526765 - Hypofractionated frameless stereotactic intensity-modulated radiotherapy with whole bra...
17108065 - Phase ii study of cloretazine for the treatment of adults with recurrent glioblastoma m...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2007-08-16
Journal Detail:
Title:  Critical reviews in oncology/hematology     Volume:  65     ISSN:  1040-8428     ISO Abbreviation:  Crit. Rev. Oncol. Hematol.     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-01-07     Completed Date:  2008-08-28     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  8916049     Medline TA:  Crit Rev Oncol Hematol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  164-71     Citation Subset:  IM    
Division of Medical Oncology A, Department of Medical Oncology, National Tumor Institute, Via M. Semmola, 80131 Naples, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Factors
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols / adverse effects,  therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy*,  pathology,  secondary
Deoxycytidine / administration & dosage,  adverse effects,  analogs & derivatives*
Disease-Free Survival
Drug Toxicity
Lung Neoplasms / drug therapy*,  pathology,  secondary
Middle Aged
Paclitaxel / administration & dosage*,  adverse effects
Retrospective Studies
Survival Rate
Reg. No./Substance:
33069-62-4/Paclitaxel; 951-77-9/Deoxycytidine; B76N6SBZ8R/gemcitabine
P Comella / ; G Frasci / ; A Avallone / ; R Costanzo / ; A Gambardella / ; M Bianco / ; D Bilancia / ; F Buzzi / ; R Bartolucci / ; R Cioffi / ; V Messina / ; P Carnicelli / ; G De Cataldis / ; F Del Gaizo / ; S Del Prete / ; L Di Lullo / ; A Farris / ; C Putzu / ; G Filippelli / ; V Olivito / ; G Dima / ; M Guida / ; A Iannelli / ; G Condemi / ; S Mancarella / ; L Maiorino / ; M Musicò / ; B Massidda / ; M T Ionta / ; E Mereu / ; P Masullo / ; D Muci / ; A Paccagnella / ; N Panza / ; S Palmeri / ; M Vaglica / ; M Roselli / ; S Mariotti / ; V Milia / ; D Natale / ; M Ghiani / ; E Barbato /

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Coronary atherosclerosis of the donor heart--impact on early graft failure.
Next Document:  Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast canc...